Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study.

Bernard Sean Regidor,Scott Jew,Marissa-Skye Goldwater,Bethany Marie Beatty,Sean Bujarski,Adam ElSayed, Ryan Danis,Susanna Kim,Regina Swift,Gary Schwartz,James R Berenson

European journal of haematology（2023）

引用 0|浏览6

暂无评分

摘要

This study shows that the two-drug class combination of ISAdm is an effective and well tolerated treatment option for RRMM patients exhibiting only BP.

查看译文

关键词

anti-CD38, isatuximab, multiple myeloma, relapsed, refractory

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要